Works matching DE "APREMILAST"

Results: 207

Long-Term Effectiveness and Drug Survival of Apremilast in Treating Psoriasis: A Real-World Experience.

Published in:

Dermatology (10188665), 2022, v. 238, n. 2, p. 267, doi. 10.1159/000515763

By:

Distel, Julian;
Cazzaniga, Simone;
Seyed Jafari, S. Morteza;
Emelianov, Vladimir;
Schlapbach, Christoph;
Yawalkar, Nikhil;
Heidemeyer, Kristine

Publication type:

Article

Key Advances in Oral Therapies for Psoriasis Unveiled at Winter Clinical Dermatology Conference 2025.

Published in:

2025

By:

Jennings, Sydney

Publication type:

Abstract

Plaque-Psoriasis: Langzeitdaten bestätigen positives Sicherheitsprofil von Deucravacitinib.

Published in:

Kompass Dermatologie, 2024, v. 12, n. 4, p. 219, doi. 10.1159/000542195

By:

Sondermann, Wiebke

Publication type:

Article

Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE Study.

Published in:

Rheumatology & Therapy, 2024, v. 11, n. 2, p. 443, doi. 10.1007/s40744-024-00641-w

By:

Chandran, Vinod;
Bessette, Louis;
Thorne, Carter;
Sheriff, Maqbool;
Rahman, Proton;
Gladman, Dafna D.;
Anwar, Sabeen;
Jelley, Jennifer;
Gaudreau, Anne-Julie;
Chohan, Manprit;
Sampalis, John S.

Publication type:

Article

Usage and Adherence of Seven Advanced Therapies with Differing Mechanisms of Action for Inflammatory Arthritis in Canada.

Published in:

Rheumatology & Therapy, 2022, v. 9, n. 5, p. 1399, doi. 10.1007/s40744-022-00485-2

By:

Nantel, Francois;
Ling, Juejing;
Rachich, Meagan;
Asin-Milan, Odalis;
Millson, Brad;
Golden, Shane;
Yang, Huijuan;
Barot, Purva;
Lehman, Allen J.

Publication type:

Article

PDE4 Inhibition Reduced Osteoclast Differentiation in Psoriatic Patients.

Published in:

Life (2075-1729), 2025, v. 15, n. 3, p. 467, doi. 10.3390/life15030467

By:

Raimondo, Annunziata;
Balestrino, Alessia;
Lembo, Serena

Publication type:

Article

Effects on Lipid Profile after One Year of Apremilast Therapy in Patients with Psoriasis: A Monocentric Experience.

Published in:

Life (2075-1729), 2024, v. 14, n. 3, p. 395, doi. 10.3390/life14030395

By:

Guerra, Prisca;
Di Cesare, Antonella;
Rosi, Elia;
Scandagli, Ilaria;
Silvi, Gianmarco;
Nunziati, Giulia;
Prignano, Francesca

Publication type:

Article

Apremilast in chronic graft-versus-host disease: a paediatric case report.

Published in:

Clinical & Experimental Dermatology, 2025, v. 50, n. 5, p. 1029, doi. 10.1093/ced/llae494

By:

Sobral-Costas, Tristán Gabriel;
Escudero-Tornero, Rafael;
Maseda, Rocío;
Castillo, Yasmina Mozo del;
Feito-Rodríguez, Marta

Publication type:

Article

Assessing the 5-year persistence in positive clinical response with innovative psoriasis treatments: a network meta-analysis of Psoriasis Area and Severity Index score.

Published in:

Clinical & Experimental Dermatology, 2024, v. 49, n. 10, p. 1148, doi. 10.1093/ced/llae131

By:

Husein-ElAhmed, Husein;
Husein-ElAhmed, Sara

Publication type:

Article

Apremilast for the treatment of papuloerythroderma of Ofuji.

Published in:

Clinical & Experimental Dermatology, 2023, v. 48, n. 11, p. 1282, doi. 10.1093/ced/llad265

By:

Xufeng Yin;
Chen Huang;
Yifei Feng;
Jiping Xia;
Meihua Zhang;
Zhiqiang Yin

Publication type:

Article

Evolving utility of apremilast in dermatological disorders for off‐label indications.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 12, p. 2136, doi. 10.1111/ced.15377

By:

Mehta, Hitaishi;
Sharma, Apoorva;
Dogra, Sunil

Publication type:

Article

Apremilast: A Review in Oral Ulcers of Behçet's Disease.

Published in:

Drugs, 2020, v. 80, n. 2, p. 181, doi. 10.1007/s40265-019-01253-3

By:

Deeks, Emma D.

Publication type:

Article

Apremilast: A Review in Psoriasis and Psoriatic Arthritis.

Published in:

Drugs, 2017, v. 77, n. 4, p. 459, doi. 10.1007/s40265-017-0709-1

By:

Keating, Gillian

Publication type:

Article

PDE4 Gene Family Variants Are Associated with Response to Apremilast Treatment in Psoriasis.

Published in:

Genes, 2024, v. 15, n. 3, p. 369, doi. 10.3390/genes15030369

By:

Liadaki, Kalliopi;
Zafiriou, Efterpi;
Giannoulis, Themistoklis;
Alexouda, Sofia;
Chaidaki, Kleoniki;
Gidarokosta, Polyxeni;
Roussaki-Schulze, Angeliki-Viktoria;
Tsiogkas, Sotirios G.;
Daponte, Athina;
Mamuris, Zissis;
Bogdanos, Dimitrios P.;
Moschonas, Nicholas K.;
Sarafidou, Theologia

Publication type:

Article

Worsening of Lymphopenia during Apremilast Treatment.

Published in:

Case Reports in Dermatology, 2016, v. 8, n. 3, p. 319, doi. 10.1159/000452321

By:

Kolios, Antonios G.A.;
French, Lars E.;
Navarini, Alexander A.

Publication type:

Article

Biologic Initiation Rate in Systemic-Naïve Psoriatic Arthritis Patients Starting Treatment with Apremilast vs Methotrexate: 1-Year Retrospective Analysis of a US Claims Database.

Published in:

Open Access Rheumatology: Research & Reviews, 2022, v. 14, p. 123, doi. 10.2147/OARRR.S342123

By:

Husni, M Elaine;
Chang, Eunice;
Broder, Michael S;
Paydar, Caleb;
Bognar, Katalin;
Desai, Pooja;
Klyachkin, Yuri;
Khilfeh, Ibrahim

Publication type:

Article

Cost-effectiveness analysis of secukinumab versus other biologics and apremilast in the treatment of active Psoriatic arthritis: a Finnish perspective.

Published in:

Cost Effectiveness & Resource Allocation, 2018, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12962-018-0162-3

By:

Purmonen, Timo;
Puolakka, Kari;
Bhattacharyya, Devarshi;
Jain, Minal;
Martikainen, Janne

Publication type:

Article

What insights can be gained from optimizing the relevant research on methotrexate monotherapy versus methotrexate and apremilast combination therapy in the treatment of palmoplantar psoriasis?

Published in:

Indian Journal of Dermatology, Venereology & Leprology, 2024, v. 90, n. 2, p. 1, doi. 10.25259/IJDVL_337_2023

By:

Si, Weichen;
Wang, Zihan

Publication type:

Article

Darier disease responding to apremilast: Report of two cases.

Published in:

Indian Journal of Dermatology, Venereology & Leprology, 2024, v. 90, n. 2, p. 1, doi. 10.25259/IJDVL_83_2023

By:

Afroditi Kleidona, Ileana;
Agiasofitou, Efthymia;
Tsiogka, Aikaterini;
Chorti, Marina;
Gregoriou, Stamatios;
Stratigos, Alexander;
Rigopoulos, Dimitrios;
Kontochristopoulos, George

Publication type:

Article

Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet's disease: A systematic review and meta-analysis.

Published in:

Modern Rheumatology, 2022, v. 32, n. 6, p. 1153, doi. 10.1093/mr/roab098

By:

Yuki Iizuka;
Kaoru Takase-Minegishi;
Hirahara, Lisa;
Yohei Kirino;
Yutaro Soejima;
Ho Namkoong;
Nobuyuki Horita;
Ryusuke Yoshimi;
Masaki Takeuchi;
Mitsuhiro Takeno;
Nobuhisa Mizuki;
Hideaki Nakajima

Publication type:

Article

Lichenoid dysplasia treated by apremilast - report of two cases and review of literature.

Published in:

Journal of Family Medicine & Primary Care, 2025, v. 14, n. 4, p. 1566, doi. 10.4103/jfmpc.jfmpc_1810_24

By:

Sil, Shiladitya;
Pyne, Rudra;
Shome, Sayani;
Dutta, Soumyajit

Publication type:

Article

Impact of Renal Impairment on the Pharmacokinetics of Apremilast and Metabolite M12.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 469, doi. 10.1002/cpdd.256

By:

Liu, Yong;
Zhou, Simon;
Assaf, Mahmoud;
Nissel, Jim;
Palmisano, Maria

Publication type:

Article

Clinical and molecular insights into cardiovascular disease in psoriatic patients and the potential protective role of apremilast.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1459185

By:

Barbarroja, Nuria;
López-Medina, Clementina;
Escudero-Contreras, Alejandro;
la Rosa, Iván Arias-de

Publication type:

Article

Activity of apremilast in a patient with severe pemphigus vulgaris: case report.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1404185

By:

Delvaux, Cheyenne;
Bohelay, Gérôme;
Sitbon, Ishaï-Yaacov;
Soued, Isaac;
Alexandre, Marina;
Cucherousset, Joël;
Gilardin, Laurent;
Diep, Antoine;
Caux, Frédéric;
Le Roux-Villet, Christelle

Publication type:

Article

Successful treatment with apremilast for palmar, yet not plantar, plaque psoriasis in a pediatric patient.

Published in:

Our Dermatology Online / Nasza Dermatologia Online, 2023, v. 14, n. 2, p. 219, doi. 10.7241/ourd.20232.25

By:

Natsumi Norikawa;
Toshiyuki Yamamoto

Publication type:

Article

Successful Remission with Combination of Diphenylcyclopropenone and Apremilast in Refractory Extensive Alopecia Areata.

Published in:

International Journal of Trichology, 2024, v. 16, n. 1, p. 47, doi. 10.4103/ijt.ijt_68_22

By:

Chikhalkar, Siddhi B;
Gupta, Savera;
Chopade, Snehal Umesh;
Jadhav, Sushanti;
Kharkar, Vidya

Publication type:

Article

Effects of the Antiobesity Drugs Aplex and Venera on Certain Biochemical and Physiological Indices in Obese Adult Male Albino Rats.

Published in:

Advances in Pharmacological & Pharmaceutical Sciences, 2022, p. 1, doi. 10.1155/2022/3776676

By:

Elpasty, Suzan S. A.;
Helal, Eman G. E.;
Algendy, Ashraf M. M.;
Yousef, Hany N.

Publication type:

Article

Apremilast Ameliorates Experimental Arthritis <italic>via</italic> Suppression of Th1 and Th17 Cells and Enhancement of CD4<sup>+</sup>Foxp3<sup>+</sup> Regulatory T Cells Differentiation.

Published in:

Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01662

By:

Chen, Weiqian;
Wang, Julie;
Xu, Zhenjian;
Huang, Feng;
Qian, Wenbin;
Ma, Jilin;
Wee, Hwa bok;
Lewis, Gregory S.;
June, Rayford R.;
Schafer, Peter H.;
Lin, Jin;
Zheng, Song Guo

Publication type:

Article

Author Correction: Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus.

Published in:

2023

By:

Sigmund, Anna M.;
Winkler, Markus;
Engelmayer, Sophia;
Kugelmann, Daniela;
Egu, Desalegn T.;
Steinert, Letyfee S.;
Fuchs, Michael;
Hiermaier, Matthias;
Radeva, Mariya Y.;
Bayerbach, Franziska C.;
Butz, Elisabeth;
Kotschi, Stefan;
Hudemann, Christoph;
Hertl, Michael;
Yeruva, Sunil;
Schmidt, Enno;
Yazdi, Amir S.;
Ghoreschi, Kamran;
Vielmuth, Franziska;
Waschke, Jens

Publication type:

Correction Notice

Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-022-35741-0

By:

Sigmund, Anna M.;
Winkler, Markus;
Engelmayer, Sophia;
Kugelmann, Daniela;
Egu, Desalegn T.;
Steinert, Letyfee S.;
Fuchs, Michael;
Hiermair, Matthias;
Radeva, Mariya Y.;
Bayerbach, Franziska C.;
Butz, Elisabeth;
Kotschi, Stefan;
Hudemann, Christoph;
Hertl, Michael;
Yeruva, Sunil;
Schmidt, Enno;
Yazdi, Amir S.;
Ghoreschi, Kamran;
Vielmuth, Franziska;
Waschke, Jens

Publication type:

Article

Effect of Oral Drug Apremilast on Histopathological Changes in Patients of Plaque Psoriasis: A Prospective Observational Study.

Published in:

Journal of Clinical & Diagnostic Research, 2023, v. 17, n. 3, p. 1, doi. 10.7860/JCDR/2023/60263.17537

By:

Singh, Yogendra;
Bagaria, Ashish;
Bagaria, Bhawna;
Gupta, Yogesh

Publication type:

Article

A greener RP-HPTLC-densitometry method for the quantification of apremilast in nanoformulations and commercial tablets: Greenness assessment by analytical eco-scale, ChlorTox, and AGREE methods.

Published in:

Arabian Journal of Chemistry, 2024, v. 17, n. 2, p. N.PAG, doi. 10.1016/j.arabjc.2023.105571

By:

Shakeel, Faiyaz;
Alam, Prawez;
Alqarni, Mohammed H.;
Iqbal, Muzaffar;
Khalid Anwer, Md.;
Alshehri, Sultan

Publication type:

Article

Waiting to initiate apremilast: evidence of disease burden and topical cycling in mild-to-moderate psoriasis in real-world clinical practice.

Published in:: Journal of Clinical & Aesthetic Dermatology, 2024, v. 17, p. S35
Publication type:: Article

Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial.

Published in:: Journal of Clinical & Aesthetic Dermatology, 2024, v. 17, p. S32
Publication type:: Article

Is Apremilast a Safe Option in Patients with History of Melanoma? A Case Series and a Review of the Literature.

Published in:

2022

By:

GAMBARDELLA, ALESSIO;
LICATA, GAETANO;
DE ROSA, ALINA;
CALABRESE, GIULIA;
ALFANO, ROBERTO;
ARGENZIANO, GIUSEPPE

Publication type:

Case Study

Oral Apremilast for the Treatment of Plaque Psoriasis.

Published in:

2016

By:

Del Rosso, James Q.;
Kircik, Leon

Publication type:

journal article

Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis.

Published in:

Therapeutics & Clinical Risk Management, 2023, v. 19, p. 413, doi. 10.2147/TCRM.S388324

By:

Jin, Joy Q;
Spencer, Riley K;
Reddy, Vidhatha;
Bhutani, Tina;
Liao, Wilson

Publication type:

Article

Analysis of Inflammatory Factors Levels and Safety in the Treatment of Psoriasis with Apremilast.

Published in:

Indian Journal of Pharmaceutical Sciences, 2022, v. 84, p. 232

By:

NI KONG;
CHONG LIU

Publication type:

Article

SMALL MOLECULES, BIG EXPECTATIONS FOR PATIENTS WITH PSORIASIS ON APREMILAST.

Published in:

Dermatovenerologia Journal, 2023, v. 68, n. 3, p. 7

By:

MUTU, COSTINA-CRISTIANA;
BUCUR, ŞTEFANA;
ŞERBAN, ELENA-DANIELA;
SAVU, ALEXANDRA-PETRUÞA;
VAIDA, CEZARA-DIANA;
OLTEANU, RODICA;
NICOLESCU, ALIN CODRUÞ;
CONSTANTIN, MARIA-MAGDALENA

Publication type:

Article

Baseline Pathological Liver Function Tests in Patients With Psoriasis Support the Indication for Systemic Therapy Rather Than Being a Reason Against It: A Real-World Analysis.

Published in:

Psoriasis: Targets & Therapy, 2025, v. 15, p. 29, doi. 10.2147/PTT.S502296

By:

Krefting, Frederik;
Scheib, Cosima;
Benson, Sven;
Hölsken, Stefanie;
Placke, Jan-Malte;
Wedemeyer, Heiner;
Sondermann, Wiebke

Publication type:

Article

An Open-Label, Randomized, Prospective, Comparative, Three-Arm Clinical Trial to Evaluate the Safety and Effectiveness of Apremilast with Three Different Titration Methods in Patients with Chronic Plaque Psoriasis in India.

Published in:

Psoriasis: Targets & Therapy, 2022, v. 12, p. 53, doi. 10.2147/PTT.S357184

By:

Viswanath, Vishalakshi;
Joshi, Pradnya;
Lawate, Prakash;
Tare, Dakshata;
Dhoot, Dhiraj;
Mahadkar, Namrata;
Barkate, Hanmant

Publication type:

Article

Efficacy of apremilast for psoriasis: a meta-analysis of randomized controlled studies.

Published in:

Advances in Dermatology & Allergology / Postępy Dermatologii i Alergologii, 2023, v. 40, n. 1, p. 165, doi. 10.5114/ada.2022.119081

By:

Yashu Liu;
Yuting Li;
Hanghang Du

Publication type:

Article

Apremilast in psoriasis and beyond: Big hopes on a small molecule.

Published in:: Indian Dermatology Online Journal, 2019, v. 10, n. 1, p. 1, doi. 10.4103/idoj.IDOJ_437_18
Publication type:: Article

Treating moderate plaque psoriasis: prospective 6-month chart review of patients treated with apremilast.

Published in:

Journal of Dermatological Treatment, 2019, v. 30, n. 5, p. 430, doi. 10.1080/09546634.2018.1528326

By:

Knuckles, Melissa L. F.;
Levi, Eugenia;
Soung, Jennifer

Publication type:

Article

Simultaneous Estimation of Apremilast and Betamethasone Dipropionate in Microsponge-Based Topical Formulation using a Stability Indicating RP-HPLC Method: A Quality-by-Design Approach.

Published in:

Journal of Chromatographic Science, 2021, v. 59, n. 10, p. 928, doi. 10.1093/chromsci/bmab016

By:

Mullick, Prashansha;
Mutalik, Sadhana P;
Hegde, Aswathi R;
Pandey, Abhijeet;
Jagadish, P C;
Kini, Suvarna G;
Jain, Sanyog;
Mutalik, Srinivas

Publication type:

Article

Formulation characterization of lecithin organogel as topical drug delivery system for psoriasis: In‐vitro permeation and preclinical evaluation.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22191

By:

Bule, Prajakta;
Kadkanje, Prashant;
Kshirsagar, Ravikiran;
Puppala, Eswara Rao;
Naidu, Vegi Ganga Modi;
Chella, Naveen

Publication type:

Article

Safety assessment of apremilast: real-world adverse event analysis from the FAERS database.

Published in:

Archives of Dermatological Research, 2025, v. 317, n. 1, p. 1, doi. 10.1007/s00403-025-04193-z

By:

Ren, Landong;
Zhao, Kaidi;
Wang, Bingqing;
Xiao, Shengxiang;
Liu, Jiashu;
Tu, Chen

Publication type:

Article

Safety assessment of apremilast: real-world adverse event analysis from the FAERS database.

Published in:

Archives of Dermatological Research, 2025, v. 317, n. 1, p. 1, doi. 10.1007/s00403-025-04193-z

By:

Ren, Landong;
Zhao, Kaidi;
Wang, Bingqing;
Xiao, Shengxiang;
Liu, Jiashu;
Tu, Chen

Publication type:

Article

Systematic review of biologic use for psoriasis in HIV-positive individuals from 2018 to 2024.

Published in:

2025

By:

Shimon, Stephanie V.;
Romanelli, Paolo

Publication type:

Literature Review

Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV–VI.

Published in:

Archives of Dermatological Research, 2023, v. 315, n. 2, p. 215, doi. 10.1007/s00403-022-02343-1

By:

Kim, Hee J.;
Del Duca, Ester;
Pavel, Ana B.;
Singer, Giselle K.;
Abittan, Brian J.;
Chima, Margot A.;
Kimmel, Grace;
Bares, Jennifer;
Baum, Danielle;
Gagliotti, Matthew;
Genece, Jordan;
Chu, Justin;
Lebwohl, Mark G.;
Guttman-Yassky, Emma

Publication type:

Article